Name
dxlabs OÜ
Registry code
11503052
VAT number
EE101276966
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
05.05.2008 (16)
Financial year
01.01-31.12
Capital
2 540.00 €
Activity
72111 - Research and experimental development on biotechnology
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| BIOINF OÜ 11359595 | 45% - 1 143.00 EUR | - | - | Founder |
| OÜ IndiPro 11371231 | 45% - 1 143.00 EUR | - | - | Founder |
| Kaia Palm 13.05.1964 (60) | - | Board member | Direct ownership | |
| Omanikukonto: TOOMAS NEUMAN 22.04.1953 (71) | - | Board member | Direct ownership | |
| Madis Prink 10.12.1985 (38) | - | Board member | - |
| 2019 30.10.2020 | 2020 29.06.2021 | 2021 12.07.2022 | 2022 03.07.2023 | |
|---|---|---|---|---|
| Total Revenue | 32 893 € | 19 639 € | 22 768 € | 15 533 € |
| Net profit (loss) for the period | -37 185 € | -7 216 € | 17 347 € | 775 € |
| Profit Margin | -113% | -37% | 76% | 5% |
| Current Assets | 84 973 € | 77 857 € | 99 719 € | 111 842 € |
| Fixed Assets | 0 € | 0 € | - | - |
| Total Assets | 84 973 € | 77 857 € | 99 719 € | 111 842 € |
| Current Liabilities | 144 € | 244 € | 4 759 € | 16 106 € |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | 84 829 € | 77 613 € | 94 960 € | 95 736 € |
| Employees | 0 | 0 | 1 | 2 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 6 131.8 € | - | - | - |
| 2023 Q4 | 6 727.97 € | - | - | - |
| 2023 Q3 | - | 9 197.42 € | 9 820.09 € | - |
| 2023 Q2 | 4 257.36 € | 10 772.82 € | 11 530.62 € | 2 |
| 2023 Q1 | 5 625.22 € | 7 954.92 € | 8 475.56 € | 3 |
| 2022 Q4 | 2 769.94 € | 7 683.06 € | 8 180.82 € | 2 |
| 2022 Q3 | 5 253.03 € | 6 397.67 € | 6 836.87 € | 2 |
| 2022 Q2 | 1 201.51 € | 3 826.89 € | 4 148.97 € | 1 |
| 2022 Q1 | 4 268.55 € | 3 826.89 € | 4 148.97 € | 1 |
| 2021 Q4 | 4 396.57 € | 3 826.89 € | 4 148.97 € | 1 |
| 2021 Q3 | 6 628.12 € | 2 802.3 € | 2 765.98 € | 1 |
| 2021 Q2 | 5 455.55 € | - | - | 1 |
| 2021 Q1 | 2 951.88 € | 4 € | - | - |
| 2020 Q4 | 5 395.05 € | 449.1 € | - | - |
| 2020 Q3 | 1 949.66 € | - | - | - |
| 2020 Q2 | 3 144.13 € | - | - | - |
| 2020 Q1 | 6 268.08 € | - | - | - |
